YearENDR1 result from 2021.1 Month away from 2022.
2022 Plans are for "the biggest drill campaign ever for ENDR"
The financial situation is not on solid ground. If the results are lackluster this company will really be in a tight squeeze.
Talk about J/Vs,bulk sample or selling assets seems like a way to get funding but doesn't look like there would be a premium.
Now,Ceo talking about "tomcat"<--Interviewer brings this property up.Don't know why.
Ceo should at least give a year end update or get some information from MSALABS about the approx time assays are to be out.
AdCap got a freeride. 1 Interview for 48,000 and shares.This marketing campaign was premature.
$17M(.38warrants 40M) and if no exercise 85M shares@.20(est for new finance deal)
If not invested currently probably better to wait until "cash" arrives.
I'm onboard the boat(feels like an iceberg ahead)
The property package has potential.
Buy more Q3-2022 dependant on how early drills start or maybe Jan 2023 for 2022 results.